Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
New insulin glargine formulation versus Lantus in insulin-naive adults with type 2 diabetes mellitus
2012-000146-35Phase 3Completed
- Sponsor
- Sanofi
- Start
- Aug 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of insulin glargine in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Sanofi. Primary endpoint: Change in HbA1c. Started Aug 2012; status: completed.
02
Drugs
insulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2012-000146-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000146-35.